|
|
 |
|
Viewing report
|
|
|
|
Epidemiology: Benign Prostatic Hyperplasia - Expected to continue growing as the male population ages
Datamonitor, July 2011, Pages: 36
Introduction
In 2010, Datamonitor estimates that there were 92.4 million prevalent cases of benign prostatic hyperplasia (BPH) in men over age 50 in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK); approximately 49% of these cases were symptomatic. The largest number of cases (28.4 million) was in the US.
Features and benefits
- Gain insight into market potential, including a robust 10-year epidemiology forecast of total and symptomatic prevalent cases of BPH.
- Understand the key epidemiologic risk factors associated with benign prostatic hyperplasia.
Highlights
Datamonitor expects to see an increase in the number of histologic benign prostatic hyperplasia (BPH) cases between 2010 and 2020 in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). The number of total BPH cases is expected to increase from approximately 79.1 million cases in 2010 to 92.4 million cases in 2020.
Datamonitor expects to see an increase in the number of symptomatic benign prostatic hyperplasia (BPH) cases between 2010 and 2020 in the seven major markets. The number of symptomatic BPH cases is expected to increase from around 38.9 million cases in 2010 to 45.8 million cases in 2020.
The largest increase in the number of BPH cases is expected in the US for both total and symptomatic BPH. Between 2010 and 2020, the number of total prevalent cases of BPH will increase by 2.2% annually and the number of symptomatic BPH cases will increase by 2.4% annually.
Your key questions answered
- What are the most robust sources for benign prostatic hyperplasia prevalence data?
- How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
- How do changes in population structure and risk factors affect the trend in prevalent benign prostatic hyperplasia cases?
|
|
|
|
